- Home
- MAIA vs ITRG Comparison
MAIA vs ITRG Comparison
Compare MAIA & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- ITRG
- Stock Information
- Founded
- MAIA 2018
- ITRG 1997
- Country
- MAIA United States
- ITRG Canada
- Employees
- MAIA N/A
- ITRG N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- MAIA Health Care
- ITRG Basic Materials
- Exchange
- MAIA Nasdaq
- ITRG Nasdaq
- Market Cap
- MAIA 46.7M
- ITRG 277.2M
- IPO Year
- MAIA 2022
- ITRG N/A
- Fundamental
- Price
- MAIA $2.06
- ITRG $1.48
- Analyst Decision
- MAIA
- ITRG Strong Buy
- Analyst Count
- MAIA 0
- ITRG 1
- Target Price
- MAIA N/A
- ITRG $2.75
- AVG Volume (30 Days)
- MAIA 425.0K
- ITRG 1.2M
- Earning Date
- MAIA 08-08-2025
- ITRG 08-13-2025
- Dividend Yield
- MAIA N/A
- ITRG N/A
- EPS Growth
- MAIA N/A
- ITRG N/A
- EPS
- MAIA N/A
- ITRG N/A
- Revenue
- MAIA N/A
- ITRG $87,375,000.00
- Revenue This Year
- MAIA N/A
- ITRG $746.16
- Revenue Next Year
- MAIA N/A
- ITRG N/A
- P/E Ratio
- MAIA N/A
- ITRG N/A
- Revenue Growth
- MAIA N/A
- ITRG N/A
- 52 Week Low
- MAIA $1.40
- ITRG $0.79
- 52 Week High
- MAIA $4.24
- ITRG $1.95
- Technical
- Relative Strength Index (RSI)
- MAIA 64.26
- ITRG 42.82
- Support Level
- MAIA $1.80
- ITRG $1.44
- Resistance Level
- MAIA $2.03
- ITRG $1.55
- Average True Range (ATR)
- MAIA 0.13
- ITRG 0.09
- MACD
- MAIA 0.03
- ITRG -0.01
- Stochastic Oscillator
- MAIA 93.88
- ITRG 18.15
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.